(Q45742035)

15 December 2017

Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease (English)

1 reference

15 December 2017

1 reference

1 reference

K Fukuda

1

1 reference

15 December 2017

D Vishnuvardhan

2

1 reference

15 December 2017

S Sekiya

3

1 reference

15 December 2017

J Hwang

4

1 reference

15 December 2017

N Kakiuchi

5

1 reference

15 December 2017

K Taira

6

1 reference

15 December 2017

K Shimotohno

7

1 reference

15 December 2017

P K Kumar

8

1 reference

15 December 2017

S Nishikawa

9

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

15 December 2017

1 reference

15 December 2017

267

1 reference

15 December 2017

12

1 reference

15 December 2017

3685-3694

1 reference

Hepatitis C: progress and problems

15 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Genetic organization and diversity of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

A second hepatitis C virus-encoded proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Structure of the hepatitis C virus RNA helicase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Amplification, mutation and selection of catalytic RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

In vitro selection of RNA molecules that bind specific ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Expression of highly active recombinant NS3 protease domain of hepatitis C virus in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Bacterial expression and analysis of cleavage activity of HCV serine proteinase using recombinant and synthetic substrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Selection of a RNA aptamer that binds to human activated protein C and inhibits its protease function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Design of selective eglin inhibitors of HCV NS3 proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Novel hepatitis C virus protease inhibitors: thiazolidine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Non-peptide inhibitors of HCV serine proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

Hepatitis C and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01400.X

10.1046/J.1432-1327.2000.01400.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference